Sentinel lymph node dissection in women with vulvar malignancies allowed gynecologic oncology surgeons to identify and remove just the sentinel nodes and follow the patients for complications and recurrence.
For women with gynecologic cancers, treatment at high-volume centers is associated with a survival advantage.
Physician communication, environmental, and patient-centered factors can improve patient satisfaction.
Carbohydrate antigen 125 (CA125) testing, already used to predict ovarian cancer recurrence, has now shown strong results as a screening technique for early-stage disease when combined with transvaginal ultrasound.
A recent study has helped clarify which women with endometrial cancer are likely to benefit from progesterone therapy.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|